CRVS- Corvus Pharmaceuticals, Inc.

CRVS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Miller Richard A Md	1.19M	$14.38M	-
CFO	Lea Leiv	400.0K	-	-
Other	Jones William Benton	400.0K	-	-
Other	Arcara Jeffrey	100.0K	-	-
Dir	Chan Andrew C.	30.0K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 28, 2022	Miller Richard A Md64	President And CEO	Buy	25,000	$0.76	$19,070.00	+1.8%	+2.4%	+85.7%
Sep 20, 2022	Miller Richard A Md64	President And CEO	Buy	20,000	$0.81	$16,253.23	+1.5%	+2.5%	+93.6%
Jun 27, 2022	Miller Richard A Md64	President And CEO	Buy	10,000	$1.01	$10,134.50	+0.7%	-32.3%	+102.8%
Jun 6, 2022	Miller Richard A Md64	President And CEO	Buy	5,890	$0.98	$5,797.20	+0.4%	-10.7%	+238.2%
Mar 31, 2022	Miller Richard A Md64	President And CEO	Buy	15,000	$1.64	$24,534.00	+1.1%	-37.8%	-44.5%
Mar 17, 2022	Lea Leiv	Chief Financial Officer	Buy	49,038	$1.57	$77,045.10	+97.7%	-38.9%	-54.6%
Mar 17, 2022	Miller Richard A Md64	President And CEO	Buy	30,000	$1.49	$44,600.00	+2.3%	-38.9%	-54.6%
Oct 1, 2021	Ecor1 Capital, LLC75	10% Owner	Sell	5,000,000	$5.01	$25,059,900.00	-98.4%	-48.9%	-83.0%
Sep 20, 2021	Orbimed Advisors LLC66	Director, 10% Owner	Sell	1,109,644	$6.09	$6,757,731.96	-13.8%	-57.4%	-87.2%
Sep 20, 2021	Thompson Peter A.63	Director, 10% Owner	Sell	1,109,644	$6.09	$6,757,731.96	-13.8%	-57.4%	-87.2%